Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5590872 | Multiple Sclerosis and Related Disorders | 2017 | 7 Pages |
Abstract
Modified premedication scheme consisting of 1Â g/day of IV methylprednisolone throughout all 5 days of alemtuzumab treatment may reduce overall IARs. Intravenous administration of antipyretics may work better than oral administration.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
SaÅ¡a Å ega-Jazbec, Barbara Barun, Alenka Horvat Ledinek, ViÅ¡nja Fabekovac, Magdalena Krbot SkoriÄ, Mario Habek,